Longitudinal study on the influence of physical activity in
managing cancer-related fatigue in patients with
colorectal cancer
16
Colorectal Cancer Metastatic dMMR Immunotherapy
(COMMIT) study: A randomized phase III study of
atezolizumab (atezo) monotherapy versus
mFOLFOX6/bevacizumab/atezo (FFX/bev) in the first-line
treatment of patients (pts) with deficient DNA mismatch
repair (dMMR) or microsatellite instability-high (MSI-H)
metastatic colorectal cancer (mCRC)—
NRG-GI004/SWOG-S1610.
14
GLP-1 receptor agonist vs aspirin for primary prevention of
colorectal cancer: Evidence from a real-world head-to-head
comparison
18
Diffusion-weighted magnetic resonance imaging versus
surgical staging in patients with colorectal peritoneal
metastases: The multicenter, international, randomized
controlled DISCO trial
15
BREAKWATER: Primary analysis of first-line (1L) encorafenib
+ cetuximab (EC) + FOLFIRI in BRAF V600E-mutant
metastatic colorectal cancer (mCRC)
13
ASCOGI 2026
COLORRECTAL
Tu canal independiente de oncología en español
Top resúmenes y presentaciones
Regístrate aquí para recibir más contenidos
Registrarse